Literature DB >> 8523515

E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors.

F Stubenrauch1, I M Leigh, H Pfister.   

Abstract

The late gene promoter P7535 of the epidermodysplasia verruciformis-associated human papillomavirus type 8 (HPV8) is regulated by the viral E2 protein. Transfection experiments performed with the human skin keratinocyte cell line RTS3b and P7535 reporter plasmids revealed transactivation at low amounts and a repression of basal promoter activity at high amounts of E2 expression vector. This repression was promoter specific and correlated with the amount of transiently expressed E2 protein. Mutational analyses revealed that the negative regulation of P7535 activity is mediated by the low-affinity E2 binding site P2, which is separated by one nucleotide from the P7535 TATA box. Biochemical and genetic analyses suggested that repression is due to a displacement of the TATA-box binding protein by E2 and an interference of E2 with promoter-activating cellular factors that specifically recognize the P2 sequence. The high conservation of the P2 sequence among several papillomaviruses (epidermodysplasia verruciformis-associated HPVs, HPV1, cottontail rabbit papillomavirus, and bovine papillomavirus type 1) in the vicinity of the late gene promoter cap site suggests that an interplay of E2 and cellular factors at this sequence element is important for the expression of structural proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8523515      PMCID: PMC189795     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA.

Authors:  E J Androphy; D R Lowy; J T Schiller
Journal:  Nature       Date:  1987 Jan 1-7       Impact factor: 49.962

2.  Transcriptional silencer of the human papillomavirus type 8 late promoter interacts alternatively with the viral trans activator E2 or with a cellular factor.

Authors:  M May; K Grassmann; H Pfister; P G Fuchs
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

3.  The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.

Authors:  S H Tan; L E Leong; P A Walker; H U Bernard
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

4.  trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.

Authors:  M Ushikai; M J Lace; Y Yamakawa; M Kono; J Anson; T Ishiji; S Parkkinen; N Wicker; M E Valentine; I Davidson
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

5.  Constitutive transcriptional activator of Epidermodysplasia verruciformis-associated human papillomavirus 8.

Authors:  S Horn; H Pfister; P G Fuchs
Journal:  Virology       Date:  1993-10       Impact factor: 3.616

6.  Low-affinity E2-binding site mediates downmodulation of E2 transactivation of the human papillomavirus type 8 late promoter.

Authors:  F Stubenrauch; H Pfister
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers.

Authors:  X P Dong; F Stubenrauch; E Beyer-Finkler; H Pfister
Journal:  Int J Cancer       Date:  1994-09-15       Impact factor: 7.396

8.  Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.

Authors:  G Dong; T R Broker; L T Chow
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1.

Authors:  M May; X P Dong; E Beyer-Finkler; F Stubenrauch; P G Fuchs; H Pfister
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

10.  Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure.

Authors:  J Ham; G Steger; M Yaniv
Journal:  EMBO J       Date:  1994-01-01       Impact factor: 11.598

View more
  14 in total

1.  The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31.

Authors:  F Stubenrauch; T Zobel; T Iftner
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300.

Authors:  Andreas Müller; Andreas Ritzkowsky; Gertrud Steger
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms.

Authors:  Andreas Müller-Schiffmann; Julia Beckmann; Gertrud Steger
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1.

Authors:  H M Schmidt; G Steger; H Pfister
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b.

Authors:  M A Ozbun; C Meyers
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

6.  Human Papillomavirus Replication Regulation by Acetylation of a Conserved Lysine in the E2 Protein.

Authors:  Yanique Thomas; Elliot J Androphy
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

7.  Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability.

Authors:  J Zhou; W J Liu; S W Peng; X Y Sun; I Frazer
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein.

Authors:  G Steger; S Corbach
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  Human papillomavirus type 8 E2 protein unravels JunB/Fra-1 as an activator of the beta4-integrin gene in human keratinocytes.

Authors:  Monika Oldak; Radoslaw B Maksym; Tanya Sperling; Moshe Yaniv; Hans Smola; Herbert J Pfister; Jacek Malejczyk; Sigrun Smola
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

Review 10.  The papillomavirus E2 proteins.

Authors:  Alison A McBride
Journal:  Virology       Date:  2013-07-10       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.